Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $141.2000 (-0.16%) ($140.9800 - $142.3750) on Mon. Nov. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.04% (three month average) | RSI | 32 | Latest Price | $141.2000(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(57%) DIA(49%) IBB(47%) SPLV(39%) VYM(37%) | Factors Impacting ABBV price | ABBV will decline at least -0.52% in a week (0% probabilities). VXX(-46%) EDOC(-46%) VIXM(-29%) GLD(-28%) USO(-24%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.52% (StdDev 1.04%) | Hourly BBV | -1.7 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $138.96(-1.59%) | Resistance Level | $145.01 | 5 Day Moving Average | $141.91(-0.5%) | 10 Day Moving Average | $142.63(-1%) | 20 Day Moving Average | $145.01(-2.63%) | To recent high | -8.7% | To recent low | 1.6% | Market Cap | $249.117b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |